# Effect of Antibiotic Choice On ReNal Outcomes (ACORN)

> **NCT05094154** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 2634 (actual)

## Conditions studied

- Sepsis
- AKI
- Neurotoxicity

## Interventions

- **DRUG:** anti-pseudomonal cephalosporin
- **DRUG:** anti-pseudomonal penicillin

## Key facts

- **NCT ID:** NCT05094154
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-10
- **Primary completion:** 2022-10-21
- **Final completion:** 2022-10-21
- **Target enrollment:** 2634 (ACTUAL)
- **Last updated:** 2023-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05094154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05094154, "Effect of Antibiotic Choice On ReNal Outcomes (ACORN)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05094154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*